Cyclosporine and the renin-angiotensin axis

Kidney International

Volumn 52, Issue 1, 1997, Pages 248-260

  Lee, David B N ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Cyclosporine; Hypertension; Renin angiotensin system

Indexed keywords

CHLORAMBUCIL; CORTICOSTEROID; CYCLOSPORIN; METHYLPREDNISOLONE;

ADULT; CASE REPORT; CHILD; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CORTICOSTEROID THERAPY; FEMALE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEMODIALYSIS; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0030844808     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.328     Document Type: Article

References (115)

1. MENDOZA SA, REZNIK VM, GRISWOLD WR, KRENSKY AM, YORGIN PD, TUNE BM: Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 4:303-307, 1990
2. SCHWARTZ GJ, HAYCOCK GB, EDELMANN CM JR, SPITZER A: A simple estimate of glomerular filtration rate in children derived from the body length and plasma creatinine. Pediatrics 58:259-263, 1976
3. MIHATSCH MJ, RYFFEL B, GUDAT F, THIEL G: Cyclosporine nephrotoxicity, in Renal Pathology with Clinical and Functional Correlations, edited by TISHER CC, BRENNER BM, Philadelphia, Lippincott, 1994, pp 1641-1681
4. MIMRAN A, MOURAD G, RIBSTEIN J, HALIMI J-M: Cyclosporin-associated hypertension, in Hypertension: Pathophysiology, Diagnosis and Management (2nd ed), edited by LARAGH JH, BRENNER BM, New York, Raven Press, 1995, pp 2459-2469
5. KOPP JB, KLOTMAN PE: Cellular and molecular mechanisms of cyclosporin nephrotoxicity. J Am Soc Nephrol 1:162-179, 1990
6. YADIN O, GRIMM P, ETTENGER R: Renal transplantation in children: Clinical aspects, in Pediatric Nephrology, edited by HOLLIDAY MA, BARRATT TM, AVNER ED, KOGAN BA, Baltimore, William & Wilkins, 1994, pp 1390-1418
7. GARDINER DS, WATSON MA, JUNOR BJR, BRIGGS JD, MORH IAR, LINDOP GBM: The effect of conversion from cyclosporin to azathioprine on renin-containing cells in renal allograft biopsies. Nephrol Dial Transplant 6:363-367, 1991
8. MYERS BD, SIBLEY R, NHWTON L, TOMLANOVICH SJ, BOSHKOS C, STINSON E, LUETSCHER JA, WHITNHY DJ, KRASNY D, COPHON NS, PERLROTH MG: The long-term course of cyclosporine-associated chronic nephropathy. Kidniy Int 33:590-600, 1988
9. BERTANI T, FERRAZZI P, SCHIEPPATI A, RUBBENENTI P, GAMBA A, PARENZAN L, MECCA G, PERICO N, IMBERTI O, REMUZZI A, REMUZZI G: Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients. Kidney Int 40:243-350, 1991
10. VERPOOTEN GA, WYBO I, PATTYN VM, HENDRIX PG, GIULIANO RA, NOUWEN EJ, ROELS F, DE BROE ME: Cyclosporine nephrotoxicity: Comparative cytochemical study of rat kidney and human allograft biopsies. Clin Nephrol (suppl 1)25:818-S22, 1986
11. NITTA K, FRIEDMAN AL, NICASTRI AD, PAIK S, FRIEDMAN EA: Granular juxtaglomerular cell hyperplasia caused by cyclosporine. Transplantation 44:417-421, 1987
12. SHEHATA M, NAHAS ME, BARKWORTH E, COPE GH, RAFTERY AT: Localization of PDGF-BB in the juxtaglomerular cells of cyclosporine-treated rats. Exp Nephrol 3:173-179, 1995
13. MASON J, MUMMER-SCHWKINITZER E, DUPONT M, CASELLAS D, MIHATSCH M, MOORE L, KASKEL F: Cyclosporine and the reninangiotensin system. Kidney Int 39(suppl 32):S28-S32, 1991
14. LUKE RG, CURTIS JJ: Biology and Treatment of transplant hypertension, in Hypertension: Pathophysiology, Diagnosis and Management (2nd ed), edited by LARAGH JH, BRENNER BM, New York, Raven Press, 1995, pp 2471-2483
15. SIEGL H, RYFFEL B: Effect of cyclosporine on renin- angiotensinaldosterone system. Lancet 2:1274, 1982
16. LUSTIG S, STERN N, EGGENA P, TUCK ML, LEE DBN:The effect of cyclosporine A on blood pressure and renin-angiotensin-aldosterone axis in spontaneously hypertensive rats. Am J physiol 253:H1596-H1600, 1987
17. CIRESI DL, LLOYD MA, SANDBERG SM, HEUBLEIN DM, EDWARDS BS: The sodium retaining effects of cyclosporine. Kidney Int 41:1599-1605, 1992
18. BAXTER CR, DUGGIN GG, HALL BM, HORVATH JS, TILLER DJ: Stimulation of renin release from rat cortical slices by cyclosporin A. Res Commun Pathol Pharmacol 43:417-423, 1984
19. LUSTIG S, EGGENA P, BARRETT J, STERN N, LEE DBN: Further studies on cyclosporine-induced hyperreninemic hypoaldosteronism: Evidence for a direct stimulatory action on renin release. Kidney Int 33:274, 1988
20. KURTZ A, BRUNA RD, KÜHN K: Cyclosporine A enhances renin secretion and production in isolated juxtaglomerular cells. Kidney Int 33:947-953, 1988
21. TUFRO-MCREDDIE A, GOMEZ, RA, NORLING LL, OMAR AA, MOORE LC, KASKEL FJ: Effect of CsA on the expression of renin and angiotensin type 1 receptor genes in the rat kidney. Kidney Int 43:614-622, 1993
22. SHEHATA M, COPE GH, BARKWORTH E, RAFTERY AT, EL NAHAS AM: The role of juxtaglomerular cells and growth factors in experimental cyclosporin nephrotoxicity (abstract). Nephrol Dial Transplant 9:919A, 1994
23. ANTONIPILLAI I, HOANG LE T, SOCENNEANTU L, HORTON R: Transforming growth factor-β is a renin secretagogue at picomolar concentrations. Am Physiol Soc 265:F537-F541, 1993
24. NAFTIMAN AJ, PRATT RE, DZAU VJ: Induction of platelet-derived growth factor A-chain and c-myc expression by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 83:1419-1424, 1989
25. STOUGGER GA, OWENS GK: Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor. Circ Res 70:820-828, 1992
26. 1 determines response to angiotensin II. J Clin Invest 90:456-461, 1992
27. ERMAN A, CHMN-GAL B, ZABLUDOWSKI J, ROSENFELD B: Cyclosporin A treatment enhances angiotensin converting enzyme activity in lung and serum of rats. J Pharm Phamacol 42:525-527, 1990
28. REGITZ-ZAGROSEK V, AUCH-SCHWELK W, HESS B, KLEIN U, DUSKE E, STEFFEN C, HILDEBRANDT AG, FLECK E: Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists. J Cardiovasc Pharmacol 26:66-72, 1995
29. MYERS BD, Ross JC, NEWTON LD, LUETSCHER JA, PERLROTH MG: Cyclosporine-associated chronic nephropathy. N Engl J Med 311: 699-705, 1984
30. HELD P, YUSUF S, MATHIAS C, DHALLA N, THEODOROPOULOS S, YACOUB M: Renin response to sympathetic stimulation in cyclosporin-treated heart transplant patients. Am J Cardiol 63:1142-1144, 1989
31. BANTLE JP, NATH KA, SUTHERLAND DER, NAJARIAN JS, FERRIS TF: Effects of cyclosporine on renin- angiotensin-aldosterone system and potassium excretion in renal transplant recipients. Arch Intern Med 145:505-508, 1985
32. CLOZEL J-P, FISCHLI W: Cyclosporin-induced hypertension in marmosets: A new model of hypertension sensitive to angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol 14:77-81, 1989
33. JULIEN J, FARGE D, KREFT-JAIS C, GUYENE T-T, PLOUIN P-F, HOUSSIN D, CARPENTIER A, CORVOL P: Cyclosporine-induced stimulation of the renin-angiotensin system after liver and heart transplantation. Transplantation 56:885-891, 1993
34. BELLET M, CABROL C, SASSANO P, LEGER P, CORVOL P, MENARD J: Systemic hypertension after cardiac transplantation: effect of cyclosporine on the renin-angiotensin system. Am J Cardiol 56:927-931, 1985
35. HEERING P, WESTHOFF A, BACH D, SPRENGER KBG, PASSLICK J, HELMCHEN U, GRABENSEE B: Renin-aldosterone system and renal function under cyclosporine A. Transplant Proc 20(suppl 3):556-562, 1988
36. BURDMANN EA, ANDOH TF, NAST CC, EVAN A, CONNORS BA, COFFMAN TM, LINDSLEY J, BENNETT WM: Prevention of experimental cyclosporine-induced interstitial fibrosis by losartan and enalapril. Am J Physiol 269:F493-F499, 1995
37. HELMCHEN U, BACH D, ROHLAND C, GROENE H-J: Dissociation of renal renin content (RRC) and plasma renin content (PRC) in cyclosporine A (CyA)-treated two kidney, one-clip hypertensive rats. Kidney Int 33:267, 1988
38. DUTZ JP, FRUMAN DA, BURAKOFF SJ, BIERER E: A role of calcineurin in degranulation of murine cytotoxic T lymphocytes. J Immunol 150:2591-2598, 1993
39. HULTSCH T, ALBERS MW, SCHREIBER SL, HOHMAN RJ: Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription. Proc Natl Acad Sci USA 88:6229-6233, 1991
40. NORLING LL, TUFRO-MCREDDIE A, GOMEZ RA, MOORE LC, KASKEL FJ: Accumulation of acidic renin isoforms in kidneys of cyclosporine-A-treated rats. J Am Soc Nephrol 7:331-337, 1996
41. OPSAHL JA, ABRAHAM PA, SHAKE JG, KATZ SA: Role of renin isoelectric heterogeneity in renal storage and secretion of renin. J Am Soc Nephrol 4:1054-1063, 1993
42. LEE J, MALVIN RL, JOKELAINEN PT: Blood pressure and acidic renin forms in stroke-prone hypertensive rats. Am J Physiol 257:F275-F279, 1989
43. SIEGL H, RYFFEL B, PETRIC R, SHOEMAKER P, MULLER A, DoNATSCH P, MIHATSCH M: Cyclosporine, the renin-angiotensin-aldosterone system, and renal adverse reactions. Transplant Proc 15(suppl 1):2719-2725, 1983
44. SHAPIRO AP, RUTAN GH, THOMPSON ME, NIGALYE RL: Hypertension following orthotopic cardiac transplantation. Cardiovasc Clin 20(2):179-188, 1990
45. NIESZPOREK T, GRZESZCZAK W, KOKOT F, ZUKOVSKA-SZCZEX-HOWSKA E, WIECEK A, KUSMIERSKI S, SZKODNY A: Does the kind of immunosuppressive therapy influence plasma renin activity, aldosterone and vasopressin in patients with a kidney transplant? Int Urol Nephrol 21(2):223-240, 1989
46. REUDELHUBER TL, MERCURE C, RAMLA D, METHOT D, POSTNOV AY: Molecular mechanisms of processing and sorting renin secretion, in Hypertension: Pathophysiology, Diagnosis and Management (2nd ed), edited by LARAGH JH, BRENNER BM, New York, Raven Press, 1995, pp 1621-1636
47. BARGER AC: The Goldblatt memorial lecture. Part I: Experimental renovascular hypertension. Hypertension 1:447-455, 1979
48. OKAMURA T, MIYAZAKI M, INAGAMI T, TODA N: Vascular reninangiotensin system in two-kidney, one-clip hypertensive rats. Hypertension 8:560-565, 1986
49. PETERS J, MUNTER M, HACKENTHAL E, MULLINS JJ, GANTEN D: Increased adrenal renin in transgenic hypertensive rats, TGR(m-REN2)27, and its regulation by cAMP, angiogensin II and calcium. J Clin Invest 91:742-747, 1993
50. MULLINS JJ, PETERS J, GANTEN D: Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344:541-544, 1990
51. JOHNSTON CI, FABRIS B, JANDELEIT K: Intrarenal renin-angiotensin system in renal physiology and pathophysiology. Kidney Int 44(suppl 42)S59-S63, 1993
52. MÜLLER-SCHWEINITZER E: Interaction of cyclosporine-A with the renin-angiotensin system in canine veins. Naunyn Schmiedebergs Arch Pharmacol 340:252-257, 1989
53. RITZ E, FLISER D, NOWICKI M: Hypertension and vascular disease as complications of diabetes, in Hypertension: Pathophysiology, Diagnosis and Management, (2nd ed), edited by LARAGH JH, BRENNER BM, New York, Raven Press, 1995, pp 2321-2334
54. ANDERSON A, JUNG FF, INGELFINGER JR: Renal renin- angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 265:F477-F486, 1993
55. LUSH DJ, KING JA, FRAY JCS: Pathophysiology of low renin syndrome: sites of renal renin secretory impairment of prorenin overexpression. Kidney Int 43:983-999, 1993
56. LUETSCHER JA, KRAEMER FB, WILSON DM, SCHWARTZ HC, BRYER-ASH M: Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N Engl J Med 312:1412-1417, 1985
57. FRANKEN AAM, DERKX FHM, MAN UB'T VELD, Hop WCJ, VAN RENS GH, PEPERKAMP E, DE JONG; PTVM, SCHALEKAMP MADH: High plasma prorenin in diabetes mellitus and its correlation with some complications. J Clin Endocrinol Metab 71:1008-1015, 1990
58. DZAU VJ: Possible prorenin activating mechanisms in the blood vessel wall. J Hypertens 5(suppl 2):S15-S18, 1987
59. SEALEY JE, VON LUTTEROTTI N, RUBATTU S, CAMPBELL WG JR, GAHNEM F, HALIMI J-M, LARAGH JH: The greater renin system. Its prorenin-directed vasodilator limb: relevance to diabetes mellitus, pregnancy, and hypertension, in Hypertension: Pathophysiology, Diagnosis and Management (2nd ed), edited by LARAGH JH, BRENNER BM, New York, Raven Press, 1995, pp 1889-1895
60. LEE DBN, NAKHOUL F, VON HUNGEN K, JAMGOTCHIAN N: Hypertensive and metabolic effects of cyclosporine, in Nephrology: Proc 4th Asian-Pacific Cong Nephrol, edited by ZANG J-H, Du X-H. LIU A-H, Li L-S, Beijing, International Academic Publishers, 1991, pp 573-583
61. NAHMAN NS JR, COSIO FG, HENRY ML, FERGUSON RM: Cyclosporine nephrotoxicity in spontaneously hypertensive rats. Transplantation 45:768-772, 1988
62. CLOZEL J-P. FISCHLI WM, MÉNARD J: Effects of the blockade of the renin-angiotensin system in cyclosporin-induced hypertension. J Hypertens 11:75-81, 1993
63. MOURAD G, RIBSTEIN J, MIMRAN A: Converting-enzyme versus calcium antagonist in cyclosporine-treated renal transplants. Kidney Int 43:419-425, 1993
64. PFEILSCHIFTER J, RUEGG UT: Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth cells. Biochem J 248:883-887, 1987
65. GÖTZE S, AUCH-SCHWELK W, BOSSALLER C, THELEN J, ELECK E: Calcium entry blockade may prevent cyclosporin A-induced hypersensitivity to angiotensin II and endothelial dysfunction in the rat aorta. Eur Heart J 14(suppl I):104-110, 1993
66. CHAN DWS, LUSTIG S, STERN N, EGGENA P, LEE DBN: Genetic susceptibility to cyclosporin (CS)-induced hypertension (HTN): Relation to adrenal resistance to angiotensin (All). Kidney Int 33:293, 1988
67. CHOI KC, PARK YS, LEE J, BAIK YH: The effects of cyclosporine on vascular responsiveness and renin release from the kidney. Transplantation 53:1157-1160, 1992
68. TEXTOR SC, SMITH-POWELL L, TELLES T: Altered pressor responses to NE and ANG II during cyclosporine A administration to conscious rats. Am J Physiol 258:H854, 1990
69. Joss DV, BARRETT AJ, KENDRA JR, LUCAS CR, DESAI S: Hypertension and convulsions in children receiving cyclosporin A. Lancet 1:906, 1982
70. TEXTOR SC, FORMAN SJ, BRAVO EL, CARLSON J: De novo accelerated hypertension during sequential cyclosporine and prednisone therapy in normotensive bone marrow transplant recipients. Transplant Proc 20(suppl 3):480-486, 1988
71. MIHATSCH MJ, THIEL G, RYFFEL B: Histopathology of cyclosporine nephrotoxicity. Transplantation Proc 20(suppl 3):759-771, 1988
72. SHULMAN L, KNECHT A, BLAU A, RAPOPORT J: Cyclosporine directly induces proliferation of renal fibroblasts in culture. J Am Soc Nephrol 4:759, 1993
73. WOLF G, KILLEN PD, NEILSON EG: Cyclosporine A stimulates transcription and procollagen secretion in tubulointerstitial fibroblasts and proximal tubular cells. J Am Soc Nephrol 1:918-922, 1990
74. GHIGGERI GM, ALTIERI P, OLEGGINI R, VALENTI R, GINEVRI F, PERFUMO F, GUSMANO R: Cyclosporine enhances the synthesis of selected extracellular matrix proteins by renal cells in "culture." Different cell responses and phenotype characterization. Transplantation 57:1382-1388, 1994
75. NAST CC, ADLER SG, ARTISHEVSKY A, KRESSER CT, AHMED K, ANDERSON PS: Cyclosporine induces elevated procollagen alpha 1 (I) mRNA levels in the rat renal cortex. Kidney Int 39:631-638, 1991
76. MYERS BD, NEWTON L, BOSHKOS C, MACOVIAK JA, FRIST WH, DERBY GC, PERLROTH MG, SIBLEY RK: Chronic injury of human renal microvessels with low-dose Cyclosporine therapy. Transplantation 46:694-703, 1988
77. PERICO N, DETCHEVA A, KAHALIL EI, REMUZZI G: Cyclosporine induces glomerulosclerosis: three-dimensional definition of the lesions of a rat model of renal transplant. Kidney Int 49:1283-1288. 1996
78. HEPTINSTALL RH: Anatomy of the Kidney, in Pathology of the Kidney (vol I, 3rd ed), edited by HEPTINSTAL RH, Boston, Little, Brown, 1983, pp 1-60
79. DIEPERINK H, STARKLINT H, KEMP E, LEYSSAC PP: Comparative pathophysiology and histopathology of Cyclosporine nephrotoxicity. Transplant Proc 20(suppl 3):785-791, 1988
80. FASEL J, KAISSLING B, LUDWIG KS, RYFFELI B, MIHATSCH MJ: Light and electron microscopic changes in the kidney of Wistar rats following treatment with Cyclosporine A. Ultrastruct Pathol 11:435-448, 1987
81. YOUNG; BA, BURDMANN EA, JOHNSON RJ, ANDOH T, BENNETT WA, COUSER WG, ALPERS CE: Cyclosporine A induced arteriolopathy in a rat model of chronic Cyclosporine nephropathy. Kidney Int 48:431-438, 1995
82. THLIVERIS JA, YATSCOFF RW, LUKOWSKI MP, COPELAND KR, JEFFERY JR, MURPHY GF: Chronic ciclosporin nephrotoxicity: a rabbit model. Nephron 57:470-476, 1991
83. ZHUO J, ALCORN D, HARRIS P, MENDELSOHN FAO: Localization and properties of angiotensin II receptors in rat kidney. Kidney Int 44(suppl 42):S40-S46, 1993
84. BOHMAN S-O: The ultrastructure of the renal medulla and the interstitial cells, in The Renal Papilla and Hypertension, edited by MANDAL AK, BOHMAN S-O, New York, Plenum, 1987, p 7
85. WOLF G, NEILSON EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 3:1531-1540, 1993
86. JOHNSON RJ, ALPERS CE, YOSHIMURA A, LOMHARDI D, PRITZL P, FLOEGE J, SCHWARTZ S: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
87. YOUNG BA, BURDMANN EA, JOHNSON RJ, ALPERS CE, GIACHELLI CM, ENG E, ANDOH T, BENNETT WM, COUSER WG: Cellular proliferation and macrophage influx precede interstitial fibrosis in Cyclosporine nephrotoxicity. Kidney Int 48:439-448, 1995
88. KANETO K, MORRISSLY J, MCCRACKEN R, REYLS AA, KLAHR S: Osteopontin expression in the kidney during ureteral obstruction (abstract). JASN 5:784, 1994
89. GIACHELLI CM, PICHLER R, LOMBARDI D, DENHARI DT, ALPERS CE, SCHWARTZ SM, JOHNSON RJ: Elevated osteopontin expression marks angiotensin II-induced renal tubulointerstitial injury and is correlated with sites of monocyte/macrophage accumulation. Kidney Int 45:515-524, 1994
90. THOMSON AW, MCAULEY FT, WHITING PH, SIMPSON JG: Angiotensin-converting enzyme inhibition or aldosterone antagonism reduces Cyclosporine nephrotoxicity in the rat. Transplant Proc 19:1242, 1987
91. LAFAYETTE RA, MAYER G, MEYER TW: The effects of blood pressure reduction on Cyclosporine nephrotoxicity in the rat. J Am Soc Nephrol 3:1892-1899, 1993
92. GILLUM DM, TRUONG L: Effects of chronic volume expansion and enalapril on chronic Cyclosporine nephropathy. Am J Physiol 258: F934-F939, 1990
93. KURTZ A: Cellular control of renin secretion. Rev Physiol Biochem Pharmacol 113:2-40, 1989
94. RASMUSSEN H: The calcium messenger system. N Engl J Med 314:1094-1101, 1164-1170, 1986
95. MORGANTI A, PELIZZOLA D, MANTERO F, GAZZANO G, OPOCHER G, PIFFANLLI A: Immunoradiometric versus enzymatic renin assay: results of the Italian Multicenter Comparative Study. J Hypertens 13:19-26, 1995
96. SEALEY JE, TRENKWALDER P, GAHNEM FM, CATANZARO D, LARAGH JH: Plasma renin methodology: inadequate sensitivity and accuracy of direct renin assay for clinical applications compared with traditional enzymatic plasma renin activity assay. J Hypertens 13:27-30, 1995
97. CURTIS JJ: Hypertension after renal transplantation: cyclosporine increases the diagnostic and therapeutic considerations. Am J Kidney Dis 13(suppl 1):28-32, 1989
98. MURRAY BM, VENUTO RC, KOHLI R, CUNNINGHAM EE: Enalaprilassociated acute renal failure in renal transplants: possible role of cyclosporine. Am J Kidney Dis 16:66-69, 1990
99. SAWAYA B, PROVENZANO R, KUPIN WL, VENKAT KK: Cyclosporine-induced renal microangiopathy. Am J Kidney Dis 12:534-537, 1988
100. SCHREIBER SL, CRABTREE GR: The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136-142, 1992
101. MCDONALD ML, ARDITO T, MARKS WH, KASHGARIAN M, LORBER MI: The effect of cyclosporine administration on the cellular distribution and content of cyclophilin. Transplantation 53(2):460-466, 1992
102. FRIEDMAN J, WEISSMAN I, FRIEDMAN J, ALPERT S: An analysis of the expression of cyclophilin C reveals tissue restriction and an intriguing pattern in the mouse kidney. Am J Pathol 144(6):1247-1256, 1994
103. OTSUKA M, TERADA Y, YANG T, NONOGUCHI H, TOMITA K, MARUMO F: Localization of cyclophilin A and cyclophilin C mRNA in murine kidney using RT-PCR. Kidney Int 45(5):1340-1345, 1994
104. VAN DEN DORPEL MA, VAN DEN MEIRAUKER AH, LAMERIS TW, BOOMSMA F, LEVI M, MAN IN 'T VELD AJ, WEIMAR W, SCHALEKAMP MADH: Cyclosporin A impairs the nocturnal blood pressure fall in renal transplant recipients. Hypertension 28:304-307, 1996
105. POISNER AM: Regulation of utero-placental prorenin. Adv Exp Med Biol 377:411-426, 1995
106. SKORECKI KL, RUTLEDGE WP, SCHRIER RW: Acute cyclosporine nephrotoxicity - prototype for a renal membrane signalling disorder. Kidney Int 42:1-10, 1992
107. GOLDBERG HJ, WONG PY, COLE EH, LEVY GA, SKORECKI KL: Dissociation between the immunosuppressive activity of cyclosporine derivatives and their effects on intracellular calcium signalling in mesangial cells. Transplantation 47:731-733, 1989
108. STERN N, LUSTIG S, PETRASOK D, JENSEN G, EGGENA P, LEE DBN, TUCK ML: Cyclosporin A-induced hyperreninemic hypoaldosteronism. A model of adrenal resistance to angiotensin II. Hypertension 9(suppl 3):III31-III35, 1987
109. CUGINI P, BATTISTI P, DI PALMA L, CAVALLINI M, POZZILLI P, SCIBILIA G, LETIZIA C, CASSISI A, CIOLI AR, MARINO B, ET AL: Secondary aldosteronism documented by plasma renin and aldosterone circadian rhythm in subjects with kidney or heart transplantation. Renal Fail 14(1):69-76, 1992
110. CUGINI P, LUCIA P, SUIBILIA G, DI PALMA L, CIOLI AR, MARINO B, CIANETTI A, GASBARRONE L, CANOVA R: Twenty-four-hour pattern of atrial natriuretic peptide in heart transplantation: evidence for lack of circadian rhythm. Temporal interrelationships with plasma renin activity, aldosterone and cortisol. Int J Cardiol 1:7-14, 1993
111. JONES JW, GRUESSNER RW, GORES PF, MATAS AJ: Hypoaldosteronemic hyporeninemic hyperkalemia after renal transplantation. Transplantation 56(4):1013-1015, 1993
112. TEXTOR SC, WILSON DJ, LERMAN A, ROMERO JC, BURNETT JC JR, WIESNER R, DICKSON ER, KROM RA: Renal hemodynamics, urinary eicosanoids, and endothelin after liver transplantation. Transplantation 54:74-80, 1992
113. FORSLUND T, HANNONEN P, REITAMO S, FYHROUIST F: Hypertension in Cyclosporin A-treated patients is independent of circulating endothelin levels. J Intern Med 238(1):71-75, 1995
114. AGUILERA S, DERAY G, DESJOBERT H, BENHMIDA M, LE HOANG P, JACOBS C: Effects of cyclosporine on tubular acidification function in patients with idiopathic uveitis. Am J Nephrol 12:425-430, 1992
115. BALLARDIE FW, EDWARDS BD, Hows J, JONES L, PETERS AM: Disturbance in renal haemodynamics and physiology in bone marrow transplant recipients treated with ciclosporin A. Nephron 60(1):17-24, 1992